Eris Lifesciences Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting

Eris Lifesciences' board approved the financial results for the quarter and half-year. Consolidated net profit for the quarter was ₹120.19 Cr, with revenue at ₹792.41 Cr. The board also proposed Krishnakumar Vaidyanathan's re-appointment as Whole Time Director and Kalpana Unadkat as Independent Director, both for five years.